![]() |
your site linked, with LinkAlert! |
|
|
|
|
|
|
|
URLwire
for Friday, December 6, 2002
By providing
early warning of outbreaks of emerging and re-emerging diseases, public
health precautions at all levels can be taken in a timely manner to prevent
epidemic transmission and to save lives.
ProMED-mail is open to all sources and free of political constraints. Sources of information include media reports, official reports, online summaries, local observers, and others. Reports are often contributed by ProMED-mail subscribers. A team of expert human, plant, and animal disease moderators screen, review, and investigate reports before posting to the network. Reports are distributed by email to direct subscribers and posted immediately on the ProMED-mail web site. ProMED-mail currently reaches about 24,000 subscribers from at least 140 countries. A central purpose of ProMED-mail is to promote communication amongst the international infectious disease community, including scientists, physicians, epidemiologists, public health professionals, and others interested in infectious diseases on a global scale. ProMED-mail encourages subscribers to participate in discussions on infectious disease concerns, to respond to requests for information, and to collaborate together in outbreak investigations and prevention efforts. ProMED-mail also welcomes the participation of interested persons outside of the health and biomedical professions. ProMED-mail was established in 1994 with the support of the Federation of American Scientists and SatelLife. Since October 1999, ProMED-mail has operated as an official program of the International Society for Infectious Diseases, a nonprofit professional organization with 20,000 members worldwide. ProMED-mail is also available in Portuguese, ProMED-PORT, and in Spanish, ProMED-ESP. Both of these lists cover disease news and topics relevant to Portuguese- and Spanish-speaking countries, respectively. ProMED-mail and ISID are grateful to the Gates Foundation, the Rockefeller Foundation, the Oracle Corporation, and an anonymous donor for financial support. Web services for ProMED-mail
are provided as a public service by the Oracle Corporation. E-mail services
are provided by the Harvard School of Public Health.
End URLwire Copy
|
. | . | The
URLwire Effect
"Eric, URLwire got our site covered and linked online in places we'd tried for months to get in without success. And, URLwire did it in one day. Thanks!!! Jim Osgood OfficeFinder.com . What is URLwire? URLwire is an email and web based news alert service for people who write about and review web sites, like Yahoo Picks of the Week or USA Today Hot Sites or WDFM. Learn more. . Editors and site reviewers looking for great sites to write about and link to. Also, online news bots like Moreover.com and Newshub syndicate this online version of URLwire . How sites get on URLwire URLwire only announces high quality, useful and unique web content. This can be a new launch, relaunch, web event, etc. I then send the announcement to online site reviewers and journalists who are looking for new web content to write about and link to. If you think your site has the right stuff, request URLwire service details/fees via Email. You can also learn more about URLwire here. . Receive URLwire Editors/site reviewers only! Subscribe to the the email version for free by sending me a brief profile of the types of sites you review and write about. Email. Editors at the below sites as well as hundreds of others are subscribers to URLwire. Sites announced via URLwire are featured regularly at these and other online news and reviews outlets: of the Week! Yahooligans! Cool Sites About.com USA Today Hot Sites & Web Guide CNet ResearchBuzz BBCi Webguide WDfM Daily Rotation MSNBC Internet.com ZDNet Traffick: The Guide To Portals WebProWire Business2.0 Kleinman Report Chris Pirillo's LockerGnome Arizona Reporter NewsIndex j.ello report WIRED Internet Tourbus Reuters |
||||||||||||||||||||||||||||
|
|
| Copyright
© URLwire. Online news headline linking services are welcome to link
to this story.
Questions or Comments |